Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06796985 · ClinicalTrials.gov registry record · Phase 1

Botox for Chronic Pelvic Pain

A Phase 1 study of Pelvic Floor Disorders, sponsored by University of Miami.

Recruiting
Registry status
Phase 1
Development phase
30
Enrollment target
1
Study location

NCT06796985 is a Phase 1 study of Pelvic Floor Disorders that is actively recruiting participants, run by University of Miami. The registered enrollment target is 30 participants, below the 113-participant average among 11 other Pelvic Floor Disorders trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06796985, a Phase 1 study of Pelvic Floor Disorders, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
Phase 1
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to find out if precise, targeted injection of botulinum neurotoxin (commonly known as Botox) provides better relief of pelvic floor hypertonicity and pain than the standard method being used. The researchers want to better understand the effects (good and bad) of targeted botulinum neurotoxin injections in women with pelvic floor disorders.

Conditions Studied

Interventions

  • DRUG Botulinum neurotoxin
  • DEVICE High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical device

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-02-24
Est. Completion 2027-03-22
Phase Phase 1

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT06796985

The ClinicalTrials.gov registry entry for NCT06796985 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 113-participant average among 11 other Pelvic Floor Disorders trials with a reported enrollment target (73% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pelvic Floor Disorders appearing as the primary indexed condition, and to 2 interventions - of which Botulinum neurotoxin is the first listed.

NCT06796985 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06796985 about?

NCT06796985 is a clinical study titled "Botox for Chronic Pelvic Pain". The purpose of this research study is to find out if precise, targeted injection of botulinum neurotoxin (commonly known as Botox) provides better relief of pelvic floor hypertonicity and pain than the standard method being used. The researchers want to better understand the effects (good and bad) o...

What is the current status of trial NCT06796985?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2025-02-24. Estimated completion is 2027-03-22.

What conditions does trial NCT06796985 study?

This clinical trial studies the following conditions: Pelvic Floor Disorders.

What interventions are being tested in trial NCT06796985?

The interventions under investigation include: Botulinum neurotoxin (DRUG), High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical device (DEVICE).

Who is sponsoring clinical trial NCT06796985?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06796985 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Floor Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.